1.1 Global state: clinically important change ‐ number of participants with clinical response |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Totals not selected |
1.2 Adverse effects: clinically important adverse effects ‐ number of participants with a delayed memory deficit |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Totals not selected |
1.3 Cognitive functioning: any change ‐ number of participants with improvement |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Totals not selected |
1.4 Cognitive functioning: average change score from baseline to endpoint of RBANS total index (high = good) |
1 |
|
Mean Difference (IV, Fixed, 95% CI) |
Totals not selected |
1.5 Mental state‐Overall: average change score from baseline to endpoint of PANSS total (high = poor) |
1 |
|
Mean Difference (IV, Fixed, 95% CI) |
Totals not selected |
1.6 Mental state‐Positive symptoms: average change score from baseline to endpoint of PANSS positive subscale (high = poor) |
1 |
|
Mean Difference (IV, Fixed, 95% CI) |
Totals not selected |
1.7 Mental state‐Negative symptoms: change scores of PANSS negative subscale (high = poor) |
1 |
|
Mean Difference (IV, Fixed, 95% CI) |
Totals not selected |
1.8 Leaving the study early: any reason |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Totals not selected |
1.9 Leaving the study early: due to adverse effect |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Totals not selected |
1.10 Leaving the study early: due to inefficacy |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Totals not selected |